Announcements Trials

Browse Landscape

Phase

Phase 1 6 Phase 2 4 Phase 1/2 4 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 4 Other hematologic neoplasm 3 Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Colonoscopy 67 Blood Specimen Collection 63 Standard of Care 59 Exercise 59 Radiosurgery 53 Drug Therapy 49 Radiofrequency Ablation 47 Endoscopic Mucosal Resection 46 Radiotherapy 45 Surgical Procedures, Operative 43 Methods 42 Early Intervention, Educational 40 Surveys and Questionnaires 39 Oxaliplatin 38 Laparoscopy 34 Educational Status 34 Fluorouracil 33 Magnetic Resonance Spectroscopy 28 Gemcitabine 26 Biopsy 26 Preoperative Exercise 25 Control Groups 24 lenvatinib 23 Practice Guidelines as Topic 23 Patient Navigation 23 Electroporation 23 Capecitabine 22 Saline Solution 20 Liver Transplantation 20 Hepatectomy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lenalidomide × Gastrointestinal × Clear all

NCT07184424 2025-09-19

Lenalidomide

Beijing Tsinghua Chang Gung Hospital

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡